Do not stop or change your medication without speaking to a pharmacist or healthcare professional.

This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →

Resolved

ROCURONIUM BROMIDE INJECTION

JUNO PHARMACEUTICALS CORP.

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of ROCURONIUM BROMIDE INJECTION in Canada?

Yes. ROCURONIUM BROMIDE INJECTION 10MG has an active shortage reported to Health Canada (last updated November 5, 2026).

Why is ROCURONIUM BROMIDE INJECTION not available?

The reason the manufacturer reported: Demand increase for the drug.

When will ROCURONIUM BROMIDE INJECTION be available again?

The manufacturer's estimated resolution date is March 15, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist
StatusResolved
Same-ingredient products on fileNone found
Affected strength10MG
Report last updated2026-10-27
Checked by MedShort2026-11-13

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02469774

Strength

10MG

Dosage Form

SOLUTION

Route

INTRAVENOUS

Active Ingredient

ROCURONIUM BROMIDE

Tier

Unrated

Last Updated

2026-10-27

Reason for Shortage

Demand increase for the drug.

Past Reports for This Drug

ROCURONIUM BROMIDE INJECTION has 2 shortage/discontinuation reports on file — this is one of them.